fda warning compounded semaglutide safety 2024 2025 Troubling Findings in Study of GLP-1 Compounders FDA Warns Against Compounded Semaglutide

Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis

First the TGA raided Como Compounding pharmacy in Melbourne, which they allege unlawfully manufactured semaglutide in bulk, a practice that isn't allowed under the exemptions due to the risk of batches being contaminated

GLP-1 therapy helps reduce cravings and appetite, but lifestyle changeslike balanced nutrition and regular activityhelp maximize results

Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels

Author contributions PP: Conceptualization, Methodology, Investigation, Resources, Writing original draft, Writing review & editing, Visualization, Supervision